CO22 Adjusting Survival Data for Treatment Crossover in the ELEVATE-TN Trial By Using a Historical Cohort of Patients Treated with Chemoimmunotherapy in Front-Line Chronic Lymphocytic Leukemia
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.120
https://www.valueinhealthjournal.com/article/S1098-3015(22)00321-7/fulltext
Section Title :
Section Order :
10099
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00321-7&doi=10.1016/j.jval.2022.04.120